IP Library › Granted Patent US 11,401,509
Granted Patent B2
US 11,401,509 · App. 15/774,138 · Granted Aug 2, 2022

Methods of minimizing glycoprotein agregation in CHO cell production

Inventor: Jun Tian (Westford, MA)
Assignee: BRISTOL-MYERS SQUIBB COMPANY
C12N5/0682C12N5/0031C12P21/005C12N2500/22C12N2500/24C12N2500/32C12N2510/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,401,509
App. No.
15/774,138
Granted
Aug 2, 2022
Kind
B2
Abstract

In accordance with the present invention, CHO cells expressing a recombinant polypeptide of interest are grown in media where the amino acids, vitamins, phosphate, lipids and/or antioxidant optimization is utilized to manipulate and/or control the protein quality attributes of the polypeptides. Polypeptides expressed in accordance with the present invention may be advantageously used in the preparation of pharmaceutical compositions.

Claims (14)

1. A method of decreasing aggregation of a recombinant glycoprotein expressed in Chinese Hamster Ovary (CHO) cells under suitable cell culture conditions comprising:

adding 1 mg/L-100 mg/L of Zinc, 1.05 g/L-2 g/L Asparagine and 0.1 g-1.05 g/L Aspartic to the cell culture medium,

wherein the cell culture medium is maintained under following conditions:

a) pH between 6.5-7.5;

b) dissolved oxygen between 5% and 90% of air saturation;

c) carbon dioxide between 10 mmHg and 150 mmHg; and

d) temperature between 30° C. and 37° C.; and

and wherein the level of aggregation of the expressed glycoprotein is decreased.

2. The method of claim 1 , wherein the cell culture medium is chemically defined.

3. The method of claim 2 , wherein the chemically defined cell culture medium is basal medium.

4. The method of claim 3 , wherein the chemically defined basal medium does not contain added serum or hydrolysates.

5. The method of claim 3 , wherein the chemically defined basal medium is protein-free.

6. The method according to claim 1 , wherein the glycoprotein is a recombinant antibody, antibody fragment or fusion protein.

7. The method according to claim 1 , wherein the cell culture process is performed under batch, fed-batch or continuous cell culture conditions.

Continuity (2)
Provisional Application 62252849 · Nov 9, 2015
Related Publication 20180312811A1 · Nov 1, 2018
Cited By (1)
US 12,234,483